Nat Habit strengthens leadership to accelerate its growth journey to 500 Cr; onboards Ankita Srivastava (ex-L’Oreal, Reckitt, Marico, Raymond Consumer Care) as Chief Marketing Officer

▴ Nat Habit
With nearly 20 years of experience in building and scaling leading brands, Ankita will build a strong brand narrative and consumer love for Nat Habit, amid a clutter of natural claiming brands. She will be instrumental in expanding Nat Habit’s portfolio to enrich the consumers’ natural beauty and wellness experience

New Delhi, 27th February 2024: Nat Habit, one of India’s fastest-growing D2C beauty and wellness brands, announced the appointment of Ankita Srivastava as Chief Marketing Officer to further accelerate its growth journey. Ankita brings almost two decades of experience in leading marketing and brand strategy, innovation and business primarily in beauty, personal care, fragrances and men’s grooming across some of India’s most loved personal care brands. Her expertise in anchoring new category entries will accelerate Nat Habit’s portfolio expansion and build a natural beauty brand that consumers trust.


The Indian beauty and wellness industry is expected to touch $30 billion by 2027, and Nat Habit aims to play a pivotal role with its focus on authentic natural offerings. With the recent infusion of $10.2 million in Series B funding, Nat Habit is in an exciting phase of expansion and innovation. Ankita will drive consumer strategy, portfolio expansion, and build a multidisciplinary team to accelerate the next phase of Nat Habit’s growth journey.


Commenting on this development, Swagatika Das, Co-Founder, Nat Habit, said, “We are thrilled to have Ankita onboard, whose expertise and proven success in building leading Beauty and Personal Care brands makes her an ideal brand leader to channel our business goals into a robust marketing strategy. Our strategic vision for the next two years involves a multi-faceted approach aimed at sustaining and scaling our presence in the beauty and personal care industry. With Ankita at the helm of our consumer-insight-driven marketing strategy, we are geared up to disrupt the space.”


On her appointment, Ankita Srivastava, Chief Marketing Officer, Nat Habit said, “The Indian Beauty and Personal Care market is undergoing a fundamental shift in the way consumers are interacting with the category and Nat Habit is all set to disrupt the market one natural ingredient at a time. Swagatika and Gaurav have created a truly differentiated brand, based on their shared passion for natural living and holistic wellness. In an era of greenwashing, their holistic vision, built on deep technical knowledge and commitment to authenticity, stands apart. We are redefining the very meaning of natural beauty, and that's a beauty revolution worth being a part of. 

Together with the leadership, I aim to scale awareness and fast-track Nat Habit’s journey to becoming a household name synonymous with natural, fresh, and authentic personal care, making natural living a habit.”


Ankita’s two decades of deep consumer expertise and strong business acumen is demonstrated in her contribution to marquee brands such as Garnier, Dettol, Parachute, Park Avenue (FMCG).

Nat Habit remains committed to its mission of simplifying, modernising, and making real natural personal care accessible to everyone - transcending boundaries with natural wisdom. Ankita’s presence will reinforce the brand’s position as a pioneer in the field of natural beauty and wellness.

About Nat Habit:

Founded in 2019, Nat Habit is a pioneering natural beauty and wellness brand that offers "Fresh Ayurveda'', a reality for the first time in India. Nat Habit lays emphasis on the use of high-quality 100% natural ingredients, authentic ayurvedic processes and fresh preparation of products in its ayurvedic kitchen. It is able to deliver on its commitment with a strong in-house R&D and a tech enabled in-house manufacturing setup. It ships products fresh everyday right to your doorstep. Nat Habit raised $10.2Mn in Series- B funding led by Bertelsmann India Investments (BII). Peak XV Partners, Fireside Ventures, Amazon India Fund, Mirabilis Investment Trust, and Sharrp Ventures are the other key investors in the brand.

Tags : #

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024
Ministry of Health Dispels Misinformation on Medicine Price Surge from April 1April 13, 2024
India’s First Indigenous CAR T-Cell Therapy Launched By President Droupadi Murmu: A New Hope in Cancer TreatmentApril 12, 2024